Clinical Trials Logo

Clinical Trial Summary

To find superiority relationship between oral and intravenous administration of tranexamic acid on peroperative and postoperative blood loss, haemarthrosis prevalence and improvement functional prognosis in anterior cruciate ligament arthroscopy.


Clinical Trial Description

Tranexamic acid is an anti-fibrinolytic drug, recommended in total hip arthroplasty to reduce peroperative and postoperative hemorrhagic complications. The original character of our study lies in the serum dosage of tranexamic acid, allowing to correlate the primary objective (blood loss) with this one. The investigators will focus on the reduction of the risks associated with the administration of intravenous medicines, the economic aspect and the ease of use. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04855877
Study type Interventional
Source University of Liege
Contact Nicolas Piette, MD
Phone 003242843824
Email [email protected]
Status Not yet recruiting
Phase Phase 4
Start date June 1, 2021
Completion date July 1, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT04390035 - BFRT in Adolescents After ACL Reconstruction N/A
Recruiting NCT02740452 - Anterior Cruciate Ligament Rupture N/A
Not yet recruiting NCT02555917 - Comparison of Remnant Preserving Versus Remnant Resecting Anterior Cruciate Ligament Reconstruction N/A
Active, not recruiting NCT00529958 - Comparison of Three Methods for Anterior Cruciate Ligament Reconstruction N/A
Terminated NCT03529552 - Evaluation After Reconstruction of the Anterior Cruciate Ligament of the Knee Using the Bioresorbable Interference Screw (SMS): Resorbability, Per- and Post-operative Complications and Articular Functional Recovery. N/A
Recruiting NCT04088227 - Effects of Platelet Rich Plasma Injections on Biomarkers After Anterior Cruciate Ligament Tears Phase 2
Recruiting NCT03671421 - Number One Overall Graft Pick? Hamstring vs Bone-Patellar-Tendon-Bone vs Quadriceps Tendon N/A
Enrolling by invitation NCT03365908 - Pain Management of ACL Reconstruction N/A
Recruiting NCT03950024 - Improvement of Knowledge About the Arthrogenic Muscle Inhibition in the Aftermath of Knee Trauma. N/A
Recruiting NCT03229369 - Association of ALL and ACL Reconstruction Versus Isolated ACL Reconstruction in High-risk Population: a RCT. N/A
Completed NCT01267435 - Evaluation of Tibial and Femoral Tunnel Position After Arthroscopic Reconstruction of the Anterior Cruciate Ligament Phase 2
Completed NCT04393129 - Central Sensitization Symptoms and Psychosocial Factors in Athletes After ACL Reconstruction
Completed NCT00975845 - BioCleanse Tibialis Tendon Anterior Cruciate Ligament (ACL) Study
Enrolling by invitation NCT04650568 - Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction N/A
Completed NCT03617991 - Functional and Self-reported Outcomes in Participants With a History of Musculoskeletal Knee Injury N/A
Recruiting NCT03758755 - Blood Flow Restriction Following ACL Reconstruction N/A
Completed NCT03680716 - Combined Saphenous Nerve and IPACK Blocks Versus Infiltration Analgesia After Anterior Cruciate Ligament Reconstruction N/A
Completed NCT03711734 - Feasibility of Electro Auricular Acupuncture for Analgesia After ACL Surgery: The Feasibility of Patient Blinding and Effects on Early Postoperative Pain N/A
Completed NCT00022854 - Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction Phase 4
Completed NCT04684771 - Tolerance, Efficacy, revAlidation, Myostim N/A